GeminIQ Website Logo

Viewing BIOE free

Start free trial

Subscribe for full history, 90+ metrics, screener, watchlist...

Bio Essence Corp

BIOE

Companies in Pharmaceutical Preparations

LLYJNJABBVMRKABTPFE

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Cash And Cash Equivalents At Carrying Value
--0--0000000
Assets
Cash
0----0------
Accounts Receivable Net Current
00000000-000
Assets Of Disposal Group Including Discontinued Op…
------011---
Advances On Inventory Purchases
0000000---00
Assets Current
Assets Current
100000111000
Other Receivables Net Current
------0001--
Prepaid Expense Current
---------000
Inventory Net
---------000
Security Deposit
-------0000-
Deposits Assets Noncurrent
---------0-0
Prepaid Expense And Other Assets Current
000000------
Deposits Assets Current
----000-----
Operating Lease Right Of Use Asset
-------111-1
Property Plant And Equipment Net
--------0000
Assets Noncurrent
Assets Noncurrent
0000-0---221
Intangible Assets Net Excluding Goodwill
000000000000
Other Assets Noncurrent
----000-01--
Assets Of Disposal Group Including Discontinued Op…
---------1--
Assets
100000122321
Bank Overdrafts
-0-00----000
Accounts Payable Current
000000000000
Deposit Liability Current
11100000----
Accounts Payable And Other Accrued Liabilities Cur…
000000000000
Finance Lease Liability Current
---------000
Liabilities Current
Liabilities Current
223333333222
Loans Payable Current
----------00
Interest Payable Current
----000000-0
Taxes Payable Current
0--------000
Operating Lease Liability Current
221111111000
Liabilities And Stockhold…
Government Assistance Liability Current
0000000000--
Operating Lease Liability Noncurrent
---000111111
Finance Lease Liability Noncurrent
---------000
Long Term Loans Payable
----------00
Liabilities Noncurrent
Liabilities Noncurrent
0000-0---111
Government Assistance Liability Noncurrent
0000000000--
Other Liabilities Noncurrent
----001-01--
Liabilities Of Disposal Group Including Discontinu…
---------1--
Liabilities
223343444443
Common Stock Value
000000000000
Stockholders Equity
Additional Paid In Capital
877777777777
Stockholders Equity
-1-2-3-3-3-3-3-2-2-2-1-1
Retained Earnings Accumulated Deficit
-9-10-11-11-11-10-10-9-9-9-9-9
Liabilities And Stockholders Equity
100000122321
Preferred Stock Par Or Stated Value Per Share
000000000000
Preferred Stock Shares Authorized
101010101010101010101010
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
100100100100100100100100100100100100
Common Stock Shares Issued
473838383838383838383838
Shares Outstanding
473838383838383838383838

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-33.42%-28.95%----------
20258.49%-55.19%-46.70%-4.21%-4.21%-25.26%-10.34%3.45%-12.07%135.29%123.53%48.82%
2024---65.85%656.10%-32.93%-19.61%-30.87%-3.54%-17.27%-14.86%-31.73%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.37
0.17
0.06
0.04
0.11
0.10
0.23
0.29
0.31
0.12
0.10
0.14
Quick Ratio
0.31
0.17
0.05
0.03
0.05
0.03
0.23
0.29
0.31
0.06
0.05
0.03
Working Capital
-1.37M
-2.02M
-3.05M
-2.96M
-2.87M
-2.52M
-2.35M
-2.19M
-2.02M
-2.15M
-1.96M
-1.31M
Leverage & Debt
Debt to Equity
-1.55
-1.20
-1.06
-1.04
-1.12
-1.09
-1.24
-2.20
-2.48
-2.66
-2.40
-2.30
Interest Coverage TTM
604.53
411.72
-57.64
-132.50
-238.02
-213.39
-304.70
-273.67
-75.28
-54.88
-12.00
-16.49
Debt Ratio
2.81
5.91
17.81
28.64
9.68
11.57
5.11
1.83
1.68
1.60
1.72
1.77
Efficiency & Turnover
Asset Turnover TTM
4.12
5.39
0.83
0.25
0.04
0.13
0.02
0.08
0.19
0.26
0.32
0.39
Days Sales Outstanding TTM
1.04
2.75
34.26
8.51
51.20
38.37
514.42
23.25
-
13.47
18.45
15.98
Receivables Turnover TTM
351.73
132.71
10.65
42.90
7.13
9.51
0.71
15.70
-
27.11
19.78
22.85
Per Share Metrics
Diluted EPS TTM
-
0.02
-
-
-
-0.03
-
-0.02
-0.02
-0.03
-0.03
-0.03
Free Cash Flow Per Share TTM
0.03
0.04
0.02
0.02
0.02
0.02
-0.00
-0.02
-0.03
-0.03
-0.03
-0.02
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
72.70%
75.32%
83.85%
108.71%
274.70%
113.49%
587.92%
73.69%
51.28%
50.31%
53.24%
59.99%
Operating Profit Margin TTM
55.60%
47.46%
-33.52%
-103.86%
-878.09%
-240.19%
-2,362.60%
-407.05%
-129.96%
-62.66%
-14.60%
-31.26%
Net Profit Margin TTM
55.02%
47.26%
-42.76%
-497.78%
-2,823.33%
-684.23%
-5,289.67%
-403.84%
-181.05%
-176.22%
-167.57%
-139.46%
Growth Metrics
Net Revenue Growth (1Y)
3,969.18%
891.40%
1,245.63%
88.70%
-83.96%
-65.32%
-95.29%
-76.72%
-44.55%
19.67%
-29.48%
-28.14%
Net Income Growth (1Y)
-179.30%
-168.47%
-89.12%
132.60%
150.11%
34.67%
48.78%
-32.60%
-12.75%
20.03%
44.26%
30.51%
EPS Growth (1Y)
-167.06%
-168.47%
-89.12%
132.60%
150.11%
20.30%
48.78%
-38.44%
-24.23%
16.69%
25.28%
24.11%
Valuation Metrics
P/E TTM
4.64
2.54
-20.14
-3.05
-5.76
-7.00
-48.19
-
-
-
-
-
P/B TTM
-4.25
-1.10
-1.04
-1.34
-2.99
-3.09
-24.16
-
-
-
-
-
P/S TTM
2.55
1.20
8.61
15.16
162.74
47.89
2,549.11
-
-
-
-
-
Market Cap
6.07M
2.28M
3.23M
4.18M
9.50M
9.16M
71.08M
-
-
-
-
-
Enterprise Value
6.03M
2.28M
3.20M
4.18M
9.50M
9.16M
71.05M
-
-
-
-
-
Calculated Values
Free Cash Flow TTM
1.18M
1.57M
751.77K
921.93K
769.41K
623.87K
-3.30K
-708.90K
-969.18K
-1.03M
-1.00M
-839.74K
Net Debt
-36.18K
0.00
-28.74K
0.00
0.00
-1.37K
-29.82K
-9.49K
-23.00
3.93K
54.41K
58.34K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-10-30Sale
Owner: Yan, Yin
Title: Chief Executive Officer
Shares: 143,845
Price/Share: $0.57
Value: $81,991.65
Shares Owned: 82,124
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2024-09-30Sale
Owner: Yan, Yin
Title: Chief Executive Officer
Shares: 1,990
Price/Share: $2.35
Value: $4,676.50
Shares Owned: 13,683,845
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2024-07-05Sale
Owner: Yan, Yin
Title: Chief Executive Officer
Shares: 6,209
Price/Share: $9.07
Value: $56,315.63
Shares Owned: 18,939,726
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2024-07-05Sale
Owner: Yan, Yin
Title: Chief Executive Officer
Shares: 73,965
Price/Share: $8.94
Value: $661,247.10
Shares Owned: 13,776,035
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2023-06-06Purchase
Owner: Yan, Yin
Title: Chief Executive Officer
Shares: 5,000,000
Price/Share: $0.50
Value: $2,500,000.00
Shares Owned: 14,000,000
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct

Subscribe to unlock 17+ years of data

Start free trial
No institutional ownership data available.

Bio Essence Corp (BIOE) — SEC Financial Statements & Analysis

Bio Essence Corp (BIOE) is a pharmaceutical preparations company, incorporated in CA. Bio Essence Corp trades on OTC as: BIOE. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Bio Essence Corp reported a 3969.18% year-over-year revenue growth, a Gross Profit Margin of 72.70% (TTM), a Debt-to-Equity ratio of -1.55x, a Price-to-Sales (P/S) ratio of 2.55x (TTM), a Price-to-Book (P/B) ratio of -4.25 (TTM), at a market cap of $6.07M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
3969.18%
Gross Profit Margin TTM
72.70%
Debt To Equity
-1.55x
P/S TTM
2.55x
P/B TTM
-4.25
Market Cap
$6.07M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Bio Essence Corp in?

Bio Essence Corp (BIOE) operates in the Pharmaceutical Preparations industry.

What is BIOE's market cap?

Bio Essence Corp (BIOE) has a market capitalization of $6.07M as of 2026-03-31.

What is BIOE's P/E ratio?

Bio Essence Corp (BIOE)'s trailing twelve month P/E ratio is 4.64x as of 2026-03-31.

What exchange does BIOE trade on?

Bio Essence Corp (BIOE) trades on the OTC.

Where is Bio Essence Corp incorporated?

Bio Essence Corp is incorporated in CA.

Research Faster.
Invest Smarter.

Start 7-day free trial

Bio Essence Corp (BIOE) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 90+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.